US 9,809,820 B2
Treatment of hyperhidrosis
Niklas Dahl, Uppsala (SE)
Assigned to Hidros Therapeutics International AB, Uppsala (SE)
Appl. No. 14/759,153
Filed by HIDROS THERAPEUTICS INTERNATIONAL AB, Uppsala (SE)
PCT Filed Dec. 13, 2013, PCT No. PCT/SE2013/051508
§ 371(c)(1), (2) Date Jul. 2, 2015,
PCT Pub. No. WO2014/107124, PCT Pub. Date Jul. 10, 2014.
Claims priority of provisional application 61/748,592, filed on Jan. 3, 2013.
Prior Publication US 2016/0122770 A1, May 5, 2016
Int. Cl. C12N 15/113 (2010.01); A61K 31/7105 (2006.01); A61K 31/713 (2006.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01)
CPC C12N 15/1138 (2013.01) [A61K 9/0019 (2013.01); A61K 9/7023 (2013.01); A61K 31/713 (2013.01); A61K 31/7105 (2013.01); C12N 2310/14 (2013.01)] 9 Claims
OG exemplary drawing
 
1. A composition for reducing sweating in humans, the composition, comprising:
a nucleic acid molecule capable of reducing levels of ITPR2 mRNA, the nucleic acid molecule being an siRNA molecule selected from the group consisting of molecules according to SEQ ID NOs: 2-3; and
one or more pharmaceutically acceptable carriers and/or excipients.